Search results
Wall Street Targets To Open Broadly Up
RTT News· 15 hours agoCorporate earnings reports might be the highlights on Tuesday. Early signs from the U.S. Futures Index suggest that Wall Street might open mostly higher. Investors anticipate the U.
Asia And Europe Markets Mixed; Crude Oil Drops Below $80 - Global Markets Today While US Slept -...
Benzinga· 6 days agoOn May 1st, U.S. stock markets closed mixed after Fed held rates steady and hinted at possible cut....
Americans’ pay gains rose faster than expected so far this year
ABC 15 Phoenix· 5 days agoA closely watched measure of labor costs showed that compensation growth accelerated much faster...
Wall Street Looks Headed For Positive Start
RTT News· 6 days agoThe market is likely to benefit from Fed Chair Jerome Powell's comments that the next rate move from the central bank will most likely be an interest rate reduction. The Dow
Asia Markets Mixed, Europe Gain While Crude Oil and Gold Fall Below Key Levels - Global Markets...
Benzinga· 5 days agoGas slid 0.29% to $2.027. Gold was trading higher by 0.02% at $2,310.10, Silver slid 0.11% to...
Wall Street Set To Open Positive
RTT News· 2 days agoEarly cues from the U.S. Futures Index suggest that Wall Street might open higher. The U.S. economic calendar for this week is relatively quiet. In the Asian trading hours, oil prices rose about ...
Asia and Europe Markets Advance; Crude Oil Back Near $80 - Global Markets Today While US Slept -...
Benzinga· 2 days agoOn Friday, U.S. stock markets surged as a softer jobs report reinforced the argument for Fed rate...
Stocks Erase Big Fed Gains; Carvana Skyrockets Late
Investor's Business Daily· 6 days agoChop and slop market continued with final-hour sell-off.
Major Asia And Europe Markets Closed For Labor Day; Dollar gains, Gold Drops To $2,300 - Global...
Benzinga· 7 days agoUS stock markets close lower on economic reports and Fed meeting. Asian markets decline, Europe...
Amgen 'very encouraged' by data from weight-loss-drug trial, as stock jumps
Morningstar· 5 days agoAmgen said that it expects firm data from an ongoing Phase 2 study of the injectable drug, MariTide, late in the year, and that plans for a "comprehensive" Phase 3 program remain on track. The ...
